Evidence map›Paper›PMID 41273732›Full record

ArticleThe American journal of case reports2025

Syphilitic Uveitis: Clinical Features, Treatment, and Outcome.

Krasina Peeva Valcheva

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Krasina Peeva ValchevaDepartment of Ophthalmology, Medical University - Pleven, Pleven, Bulgaria.ORCID 0000-0003-4963-9254

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Syphilis is a sexually transmitted infection in which ocular involvement is relatively uncommon. This report describes the clinical presentation, treatment, and visual outcome of a patient with syphilitic uveitis. CASE REPORT A 52-year-old man with a history of sexual promiscuity was diagnosed with bilateral panuveitis secondary to syphilis. He experienced progressively worsening bilateral vision loss over 1 month. The diagnosis was confirmed by serological positivity for Treponema pallidum. The patient displayed human immunodeficiency virus negativity. At presentation, visual acuity in the right eye was light perception and projection; in the left eye, it was 20/630. Ophthalmologic examination revealed non-granulomatous panuveitis, vitritis, chorioretinitis, retinal vasculitis, and papillitis. The patient was treated with intravenous aqueous penicillin G and systemic methylprednisolone for 7 days, followed by 5 weekly applications of intramuscular benzathine penicillin G. Topical therapy included antibiotic-corticosteroid, atropine sulfate, and bromfenac eye drops in both eyes. Two months after initiation of therapy, a periocular injection of methylprednisolone was administered to the right eye. Substantial improvement was observed, with final visual acuity of VOD=20/25 and VOS=20/20 after approximately 14 weeks of follow-up. CONCLUSIONS Ocular syphilis exhibits wide clinical variability. In this case, it manifested as non-granulomatous panuveitis with inflammation of the retinal vessels and optic disc. Early serologic diagnosis and prompt treatment are essential for favorable outcomes. Final visual acuity improved after systemic antibiotic and corticosteroid therapy, complemented by topical antibiotic-corticosteroid agents, cycloplegic drops, and a nonsteroidal anti-inflammatory agent.

Indexed as

Eye Infections, BacterialSyphilisUveitisAnti-Bacterial AgentsHumansMaleMethylprednisoloneMiddle AgedPenicillin GPenicillin G BenzathineAnti-Bacterial AgentsMethylprednisolonePenicillin GPenicillin G Benzathine

Identifiers

PMID41273732
PMCPMC12683950

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.